A history of polymyalgia rheumatica: a narrative review

Shirley Shah1, Sinchna Rao1, Sarah L Mackie2,3

  • 1School of Medicine, University of Leeds, Leeds, UK.

PubMed

Insights

Polymyalgia rheumatica (PMR) causes shoulder, hip, and neck pain, often in older adults. Accurate diagnosis is crucial, as treatment response is not specific, requiring collaboration for better patient outcomes.

Area of Science:

  • Rheumatology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting individuals typically in their eighth decade.
  • PMR presents with characteristic stiffness and pain in the shoulders, hips, and neck.
  • PMR can co-occur with giant cell arteritis, suggesting shared underlying pathophysiological mechanisms.

Purpose of the Study:

  • To review current understanding of Polymyalgia rheumatica (PMR) within a historical framework.
  • To examine the evolution of classification criteria and their impact on clinical diagnosis.
  • To highlight the importance of accurate diagnosis and collaborative care pathways for PMR.

Main Methods:

  • This narrative review synthesizes existing literature on Polymyalgia rheumatica (PMR).
  • The review traces the historical development of PMR nomenclature, classification criteria, and diagnostic approaches.
  • It analyzes the relationship between PMR's musculoskeletal inflammation and vasculitic/synovitic diseases.

Main Results:

  • The characteristic distribution of inflammation in PMR influences its description, classification, diagnosis, and treatment.
  • Glucocorticoid response, while common in PMR, is not pathognomonic, complicating diagnosis.
  • Effective management necessitates distinguishing PMR from other conditions and requires rheumatologist support for general practitioners.

Conclusions:

  • Accurate and timely diagnosis of Polymyalgia rheumatica (PMR) is essential for appropriate management.
  • Collaboration among healthcare professionals, including rheumatologists and general practitioners, is vital for improving diagnostic accuracy and treatment.
  • Enhanced diagnostic pathways and multi-stakeholder collaboration are needed to ensure safe and effective care for PMR patients.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
8
Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.1K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5